Regulatory Watch

RSS

The guidance describes how firms can voluntarily engage with the FDA before marketing food from genome-edited plants.

The FDA says revoking the standards will provide greater flexibility and the opportunity for product innovation.

The meeting is designed to help the agency improve its understanding of how it can leverage data and technology to exponentially advance food safety and achieve better health outcomes.

The alert gives the FDA the ability to help prevent entry of human food products into the U.S. if they are found to be contaminated with a broad range of human-made chemicals.

The U.S. Food and Drug Administration (FDA) has released a revised draft Introduction and Appendix 1 to the multi-chapter draft guidance for industry titled “Hazard Analysis and Risk-Based Preventive Controls for Human Food: Draft Guidance for Industry” (PCHF Draft Guidance).

The request includes an increase of $495 million—or 7.4 percent above the FY 2023 funding level.

The updated list includes select food ingredients (including food and color additives), food contact substances and contaminants under FDA review.

D-tagatose must be declared as an added sugar on the Nutrition Facts label, but it contains fewer calories than sucrose or table sugar.